Intra-Articular Cyclo(His-Pro) Attenuates Monosodium Iodoacetate-Induced Osteoarthritis by Suppressing COX-2/PGE2 Signaling and Cartilage Catabolism in Rats
International Journal of Molecular Sciences · 25.05.2026 · 27 (11) · 4742
DOI: 10.3390/ijms27114742 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.05.2026. Verfasst von Gyuwon Huh und 4 weiteren Autor:innen. Beteiligte Einrichtung: R&D Center, NovMetaPharma Co., Ltd., Pohang 37668, Republic of Korea. Hauptthemen laut MEDLINE: Osteoarthritis, Dinoprostone, Cyclooxygenase 2, Signal Transduction. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Industrial Technology Association, MSIT, Ministry of Education (MOE) and the Gyeongsangbuk-do, Republic of Korea.
Abstract (Originalsprache)
Osteoarthritis (OA) remains an alarming therapeutic challenge, as conventional intra-articular interventions primarily address symptomatic relief without halting progressive cartilage and bone degeneration. In this study, we investigated the disease-modifying potential of Cyclo(His-Pro) (CHP) in a monosodium iodoacetate (MIA)-induced OA rat model. Intra-articular CHP yielded significant clinical improvements, reducing joint edema and reversing OA-induced mechanical and thermal hypersensitivity, as evidenced by lifting behavior, rotarod performance, and hot plate tests. Beyond analgesia, micro-computed tomography (micro-CT) analysis showed that CHP preserved subchondral bone architecture, restoring trabecular volume and thickness and reducing serum C-terminal telopeptide of type II collagen (CTX-2), indicative of suppressed cartilage degradation. At the molecular level, CHP reprogrammed the joint microenvironment by suppressing Cox2, Adamts5, Mmp13, Mmp1, Mmp2, and Timp2 expression and decreasing systemic prostaglandin E2 (PGE2) levels. Moreover, CHP showed efficacy comparable to Conjuran, a polynucleotide-based mechanical supportive agent, while additionally targeting COX-2/PGE2-driven inflammatory cascades and cartilage catabolic pathways. Collectively, these findings indicate that intra-articular CHP confers combined analgesic, chondroprotective, and osteoprotective effects, supporting its potential as a promising disease-modifying osteoarthritis drug candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- R&D Center, NovMetaPharma Co., Ltd., Pohang 37668, Republic of Korea.
- Division of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
ORCID-Profile: Gyuwon Huh, Dohyun Lee, Jongsu Jeon, Daehun Kim
Förderung
- Korea Industrial Technology Association
- MSIT
- Ministry of Education (MOE) and the Gyeongsangbuk-do, Republic of Korea
Zitieren
APA
Huh, G., Lee, D., Jeon, J., Kim, D., & Jung, H. Y. (2026). Intra-Articular Cyclo(His-Pro) Attenuates Monosodium Iodoacetate-Induced Osteoarthritis by Suppressing COX-2/PGE2 Signaling and Cartilage Catabolism in Rats. International Journal of Molecular Sciences, 27(11), 4742. https://doi.org/10.3390/ijms27114742
Vancouver
Huh G, Lee D, Jeon J, Kim D, Jung HY. Intra-Articular Cyclo(His-Pro) Attenuates Monosodium Iodoacetate-Induced Osteoarthritis by Suppressing COX-2/PGE2 Signaling and Cartilage Catabolism in Rats. International Journal of Molecular Sciences. 2026;27(11):4742. doi:10.3390/ijms27114742
BibTeX
@article{Huh2026,
author = {Huh, Gyuwon and Lee, Dohyun and Jeon, Jongsu and Kim, Daehun and Jung, Hoe-Yune},
title = {Intra-Articular Cyclo(His-Pro) Attenuates Monosodium Iodoacetate-Induced Osteoarthritis by Suppressing COX-2/PGE2 Signaling and Cartilage Catabolism in Rats},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4742},
doi = {10.3390/ijms27114742}
}
EUVIMED